Get the Daily Brief
Latest Biotech News
Biotech Startup RedC Aims to Mass-Produce Lab-Grown Universal Blood
RedC Biotech, a budding company founded by Dr. Ari Gargir, is developing technology to cultivate red blood cells from stem cells at scale. The approach intends to create universal donor blood...
New AI Model Predicts Long-Term Stability of Biotherapeutic CHO Cell Lines
Researchers at MIT have developed and publicly released an AI-driven model that forecasts the long-term stability of Chinese Hamster Ovary (CHO) cell lines used extensively in biotherapeutic...
Phase II Data Elevate Dianthus Therapeutics in Generalized Myasthenia Gravis
Dianthus Therapeutics announced positive Phase II outcomes for its selective complement inhibitor in patients with generalized myasthenia gravis (gMG). The results indicate meeting multiple...
Mid-Stage Success with Antibody–Bottlebrush Prodrugs Enhances Cancer Therapy Options
A series of groundbreaking publications in Nature Biotechnology introduce antibody–bottlebrush prodrugs as next-generation targeted cancer therapies. These constructs allow higher drug-to-antibody...
Novartis Completes $1.4B Tourmaline Acquisition for Cardiovascular Drug
Novartis has finalized the $1.4 billion acquisition of Tourmaline Bio, securing pacibekitug, a promising anti-IL-6 monoclonal antibody targeting atherosclerotic cardiovascular disease (ASCVD)....
Rapport Therapeutics Advances with High-Efficacy Seizure Drug in Phase II
Rapport Therapeutics reported exceptional Phase II data for RAP-219, a TARPγ8-specific AMPAR modulator aimed at drug-resistant focal onset seizures. The open-label study showed a median 78%...
Eli Lilly Opens AI Platform TuneLab to Biotech Startups
Eli Lilly launched 'TuneLab,' an AI platform granting selected biotech companies access to pre-trained drug discovery models developed from Lilly’s extensive R&D data. In exchange for access,...
Breakthrough AI Model Predicts Long-Term Cell Line Stability for Biologics
Scientists at MIT unveiled the first publicly available AI model predicting long-term stability of Chinese Hamster Ovary (CHO) cell lines over 72 passages, aligning with FDA stability metrics....
Antibody–Bottlebrush Prodrugs Enhance Targeted Cancer Therapies
Innovative research published in Nature Biotechnology describes antibody–bottlebrush prodrug conjugates that expand payload diversity beyond conventional antibody–drug conjugates (ADCs). These...
New Clinical Advances in Small Cell and Non-Small Cell Lung Cancer
At the 2025 World Conference on Lung Cancer, multiple studies showcased advances in lung cancer treatment. BioNTech and Bristol Myers Squibb’s bispecific PD-L1/VEGF inhibitor pumitamig...
RedC Biotech Develops Lab-Grown Universal Blood Supply
Israeli startup RedC Biotech is pioneering large-scale production of universal-type red blood cells derived from stem cells. Utilizing expansive bioreactors, the technology aims to overcome global...
Novel Single-Cell Sequencing Trial Targets Myelodysplastic Syndrome Diagnosis
Researchers at the Weizmann Institute have initiated the PERIBLOOD clinical trial to evaluate single-cell sequencing as a minimally invasive diagnostic alternative to bone marrow biopsies for...
AI-Powered Satellite Imagery Reveals Lower Wildebeest Populations in Serengeti
Researchers from the University of Oxford deployed artificial intelligence techniques alongside high-resolution satellite imagery to reassess wildebeest populations during the Great Migration in...
ALZ-101 Alzheimer’s Vaccine Advances to Phase II Clinical Trials
Swedish biopharmaceutical company Alzinova received FDA approval to commence Phase II clinical trials for ALZ-101, a therapeutic vaccine targeting toxic amyloid-beta oligomers implicated in...
Novartis' $1.4B Acquisition of Tourmaline Bio Propels Cardiovascular Pipeline
Novartis announced the acquisition of Tourmaline Bio for $1.4 billion, obtaining exclusive rights to an anti-inflammatory heart medication nearing Phase 3 trials. The deal is set to bolster...
Rapport Therapeutics' Epilepsy Drug RAP-219 Surges on Robust Phase II Results
Rapport Therapeutics reported positive topline Phase II data for RAP-219, a TARPγ8-specific AMPAR negative allosteric modulator for focal onset seizures. The drug reduced clinical seizure...
Breakthroughs in Lung Cancer Therapy from WCLC 2025 Trials
Recent data from the 2025 World Conference on Lung Cancer have highlighted advances and challenges in the treatment of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)....
Eli Lilly Opens AI Drug Discovery Models to Biotech Partners via TuneLab
Eli Lilly launched TuneLab, a platform granting small biotech firms access to Lilly’s extensive AI models trained on decades of internal data, focusing on small-molecule drug properties and...
VedaBio Licenses Mammoth Biosciences’ CRISPR Diagnostics Technology
VedaBio secured a non-exclusive license from Mammoth Biosciences for its CRISPR-based diagnostic technologies, aiming to enhance its amplification-free diagnostic platform. The collaboration...
Alzinova's Alzheimer’s Vaccine ALZ-101 Advances to Phase II After FDA IND Approval
Alzinova announced FDA approval of its Investigational New Drug application for ALZ-101, a novel vaccine targeting toxic amyloid-beta oligomers implicated in Alzheimer’s disease. Following...